EP 3548036 A1 20191009 - NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES
Title (en)
NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES
Title (de)
NATÜRLICHE KOMBINATIONSHORMONERSATZFORMULIERUNGEN UND THERAPIEN
Title (fr)
THÉRAPIES ET FORMULATIONS HORMONALES DE SUBSTITUTION COMBINATOIRES NATURELLES
Publication
Application
Priority
- US 201662430339 P 20161205
- US 201762481060 P 20170403
- US 2017064788 W 20171205
Abstract (en)
[origin: WO2018136161A1] Pharmaceutical compositions for co-administering estradiol and progesterone to a human subject in need thereof are provided. In some embodiments, the pharmaceutical composition comprises solubilized estradiol, suspended progesterone, and a solubilizing agent comprising a medium chain (C6-C12) oil.
IPC 8 full level
A61K 31/565 (2006.01); A61K 31/57 (2006.01); A61K 47/44 (2017.01)
CPC (source: EP KR)
A61K 31/52 (2013.01 - EP); A61K 31/565 (2013.01 - EP KR); A61K 31/57 (2013.01 - EP KR); A61K 47/44 (2013.01 - KR); A61P 15/12 (2017.12 - EP KR); A61K 2300/00 (2013.01 - KR)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2018136161 A1 20180726; WO 2018136161 A9 20190822; AU 2017394679 A1 20190613; BR 112019011655 A2 20191022; CA 3045024 A1 20180726; CN 110290793 A 20190927; EP 3548036 A1 20191009; EP 3548036 A4 20200617; IL 267023 A 20190731; JP 2020504093 A 20200206; KR 20200018383 A 20200219; MX 2019006513 A 20190814; RU 2019115913 A 20210115; RU 2019115913 A3 20210319
DOCDB simple family (application)
US 2017064788 W 20171205; AU 2017394679 A 20171205; BR 112019011655 A 20171205; CA 3045024 A 20171205; CN 201780086119 A 20171205; EP 17893482 A 20171205; IL 26702319 A 20190602; JP 2019530027 A 20171205; KR 20197019625 A 20180202; MX 2019006513 A 20171205; RU 2019115913 A 20171205